Difelikefalin (CR845)

difelikefalin · Cara Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Difelikefalin (CR845), covering 2022-04-04 to 2024-05-07. Get the full timeline:

Most recent: Clinical Trial Update: CR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus [Phase 3]

See pricing